Biotechnology
TLX
16.86
price up icon0.48%   0.08
pre-market  Vorhandelsmarkt:  15.47   -1.39   -8.24%

Telix Pharmaceuticals Ltd Adr (TLX)
full-star
loading
Überblick Nachrichten Preisverlauf Forum Prognose
Schlusskurs vom Vortag:
$16.78
Offen:
$18
24-Stunden-Volumen:
17,326
Relative Volume:
1.84
Marktkapitalisierung:
$5.64B
Einnahmen:
$417.75M
Nettoeinkommen (Verlust:
$32.27M
KGV:
172.92
EPS:
0.0975
Netto-Cashflow:
-
1W Leistung:
+8.63%
1M Leistung:
+6.57%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
Value
$16.77
$18.00
1-Wochen-Bereich:
Value
$15.54
$18.04
52-Wochen-Spanne:
Value
$14.01
$18.04

Telix Pharmaceuticals Ltd Adr Stock (TLX) Company Profile

Name
Firmenname
Telix Pharmaceuticals Ltd Adr
Name
Sektor
Healthcare (1176)
Name
Branche
Biotechnology (685)
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
0
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
TLX's Discussions on Twitter

Vergleichen Sie TLX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
TLX
Telix Pharmaceuticals Ltd Adr
 16.86 5.64B 417.75M 32.27M 0 0.0975
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
 427.89 110.19B 10.63B -479.80M -1.35B -1.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
 687.80 75.58B 13.85B 4.65B 3.32B 40.41
Biotechnology icon
ARGX
Argen X Se Adr
 647.39 38.71B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
 264.99 34.18B 2.09B -332.26M 16.06M -2.62
Biotechnology icon
BNTX
Biontech Se Adr
 117.25 28.11B 3.30B -501.07M 1.03B -2.1146

Telix Pharmaceuticals Ltd Adr Stock (TLX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-11-15 Eingeleitet UBS Buy

Telix Pharmaceuticals Ltd Adr Aktie (TLX) Neueste Nachrichten

pulisher
Jan 13, 2025

Telix Presentation to the 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewswire Inc.

Jan 13, 2025
pulisher
Dec 31, 2024

ASX healthcare 2024 winners and losers, plus what’s next for 2025 - Stockhead

Dec 31, 2024
pulisher
Nov 27, 2024

Health Check: ASX sleep company emerges from slumber with a revenue and earnings upgrade - Stockhead

Nov 27, 2024
pulisher
Nov 15, 2024

UBS bullish on Telix stock—Illuccix growth & therapeutic expansion fuel upside - Investing.com

Nov 15, 2024
pulisher
Nov 13, 2024

Telix Pharmaceuticals Debuts on Nasdaq Global Select Market Under TLX Symbol - StockTitan

Nov 13, 2024
pulisher
Oct 22, 2024

Telix spins off radiopharma unit to form Rhine Pharma | Pharmaceutical | The Pharmaletter - The Pharma Letter

Oct 22, 2024
pulisher
Oct 18, 2024

Guess which top 100 ASX stock is venturing off to the Nasdaq - The Motley Fool Australia

Oct 18, 2024
pulisher
Oct 17, 2024

Telix Files Form 20-F Registration Statement for Nasdaq ADS - Yahoo Finance

Oct 17, 2024
pulisher
Jul 16, 2024

Up 66% in FY24, will Telix Pharmaceuticals shares continue? - The Motley Fool Australia

Jul 16, 2024
pulisher
Jun 14, 2024

TLX ASX: Telix pulls $300m Nasdaq IPO as investors demand deep discount - The Australian Financial Review

Jun 14, 2024
pulisher
Jan 31, 2024

Pharmaceutical Industry Mergers & Acquisitions Roundup - Contract Pharma

Jan 31, 2024
pulisher
Jan 05, 2024

Australia's Telix Pharmaceuticals jumps on potential US listing - Reuters

Jan 05, 2024
pulisher
Mar 01, 2016

Queen's University Leads Irish Trial of New Prostate Cancer Treatment - Imaging Technology News

Mar 01, 2016

Finanzdaten der Telix Pharmaceuticals Ltd Adr-Aktie (TLX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Ähnlich wie TLX

biotechnology GMAB
$21.80
price up icon 4.81%
biotechnology INCY
$73.47
price up icon 2.14%
biotechnology SMMT
$22.10
price up icon 16.13%
biotechnology UTHR
$367.97
price up icon 2.52%
biotechnology ONC
$218.70
price up icon 4.10%
biotechnology BNTX
$117.25
price up icon 4.75%
In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters
Kapitalisierung:     |  Volumen (24h):